RXO (NYSE:RXO – Get Free Report) had its price target cut by Stifel Nicolaus from $24.00 to $14.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ price target would suggest a potential downside of 3.38% from the company’s current price.
A number of other brokerages have also recently issued reports on RXO. Morgan Stanley lowered their price objective on RXO from $27.00 to $25.00 and set an “equal weight” rating for the company in a research note on Thursday, February 6th. Susquehanna lowered their price target on RXO from $18.00 to $13.00 and set a “negative” rating for the company in a research report on Wednesday, March 26th. Benchmark reissued a “hold” rating on shares of RXO in a research report on Wednesday, January 15th. Barclays decreased their target price on shares of RXO from $24.00 to $22.00 and set an “overweight” rating for the company in a report on Wednesday, April 2nd. Finally, Citigroup cut their price target on shares of RXO from $23.00 to $15.00 and set a “neutral” rating on the stock in a report on Tuesday, April 8th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, RXO has an average rating of “Hold” and an average price target of $19.93.
Read Our Latest Analysis on RXO
RXO Stock Performance
RXO (NYSE:RXO – Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.01). RXO had a positive return on equity of 1.53% and a negative net margin of 6.26%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same period in the previous year, the firm earned ($0.03) EPS. The company’s revenue was up 57.0% on a year-over-year basis. On average, equities analysts expect that RXO will post 0.31 EPS for the current fiscal year.
Institutional Trading of RXO
A number of hedge funds have recently bought and sold shares of RXO. Blue Trust Inc. grew its stake in shares of RXO by 79.7% during the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock valued at $27,000 after purchasing an additional 510 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in RXO during the third quarter valued at approximately $28,000. Smartleaf Asset Management LLC raised its position in RXO by 228.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company’s stock worth $30,000 after acquiring an additional 868 shares during the period. Larson Financial Group LLC boosted its stake in shares of RXO by 1,990.2% during the 1st quarter. Larson Financial Group LLC now owns 1,714 shares of the company’s stock worth $33,000 after acquiring an additional 1,632 shares during the last quarter. Finally, CWM LLC grew its position in shares of RXO by 234.4% during the 1st quarter. CWM LLC now owns 1,876 shares of the company’s stock valued at $36,000 after acquiring an additional 1,315 shares during the period. Hedge funds and other institutional investors own 92.73% of the company’s stock.
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Further Reading
- Five stocks we like better than RXO
- Breakout Stocks: What They Are and How to Identify Them
- Google Is Betting Big on Nuclear Reactors—Should You?
- 5 Top Rated Dividend Stocks to Consider
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- How to Invest in Insurance Companies: A GuideÂ
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.